Needham Lifts Cellebrite Price Target to $14 From $12.50
Needham analysts raised their price target on Cellebrite DI shares to $14 from $12.50. Dow Jones Newswires reported the change, citing Benzinga ratings data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Needham has raised its price target on Cellebrite DI shares to $14 from $12.50, according to Dow Jones Newswires. The report points to Benzinga's ratings records for the stock as its reference.
The source material does not include the full analyst note, so the reasoning behind the decision is not available.
why it matters
A higher price target reflects a more optimistic analyst view of the stock, but it does not guarantee any move in the share price. Such changes usually affect sentiment toward the single stock rather than the broader market.
tags
instruments
sources
- Cellebrite DI Price Target Raised to $14.00/Share From $12.50 by Needham — Dow Jones Newswires, 13 November 2026 at 10:46 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗